Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00605527 · ClinicalTrials.gov registry record
Understanding the Role of Genes and Biomarkers in the Inflammation and Blood Clotting Process in Children With Acute Lung Injury
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 396
- Enrollment target
NCT00605527 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 396 participants.
The verdict
NCT00605527 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 396 participants
- Enrollment target
Study Summary
Acute lung injury (ALI)/Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition that causes respiratory failure. This study will examine if differences in genes and biomarkers involved in the inflammation and blood clotting process may affect the severity of and recovery from ALI/ARDS in children hospitalized with the condition.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 396 participants |
| Start Date | 2007-11 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00605527
The ClinicalTrials.gov registry entry for NCT00605527 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 396 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00605527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00605527 about?
NCT00605527 is a clinical study titled "Understanding the Role of Genes and Biomarkers in the Inflammation and Blood Clotting Process in Children With Acute Lung Injury". Acute lung injury (ALI)/Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition that causes respiratory failure. This study will examine if differences in genes and biomarkers involved in the inflammation and blood clotting process may affect the severity of and recovery from ALI/ARDS ...
What is the current status of trial NCT00605527?
This trial is currently completed. The enrollment target is 396 participants. The study started on 2007-11. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT00605527?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.